Rūta Pumputienė

Rūta Pumputienė

Rūta Pumputienė is an attorney at law with over 12 years’ legal experience, specializing in life sciences sector and other regulated industries (food, tobacco, alcohol, gambling), as well as intellectual property law area. Ms Pumputienė has been recognized as one of the top life sciences legal experts in Lithuania by “Who’s who legal” and “Best Lawyers”.

Rūta is a founder and managing partner of Ruta Pumputiene Law Firm and the head of the Local American Working Group (LAWG), a standing committee established by the American Chamber in Commerce in Lithuania to tackle issues concerning the healthcare system and pharmaceutical industry in Lithuania.

She graduated from Vilnius University Faculty of Law in 2004, and in 2010 she obtained a Master of Law (LLM) degree in International Intellectual Property Law at the University of London. She has authored and co-authored legal overview chapters in numerous local and international editions, as well as analytical articles in relation to life sciences regulation in the Baltics, pharmaceutical pricing and reimbursing issues.

Rūta Pumputienė is an attorney at law with over 12 years’ legal experience, specializing in life sciences sector and other regulated industries (food, tobacco, alcohol, gambling), as well as intellectual property law area. Ms Pumputienė has been recognized as one of the top life sciences legal experts in Lithuania by “Who’s who legal” and “Best Lawyers”.

Rūta is a founder and managing partner of Ruta Pumputiene Law Firm and the head of the Local American Working Group (LAWG), a standing committee established by the American Chamber in Commerce in Lithuania to tackle issues concerning the healthcare system and pharmaceutical industry in Lithuania.

She graduated from Vilnius University Faculty of Law in 2004, and in 2010 she obtained a Master of Law (LLM) degree in International Intellectual Property Law at the University of London. She has authored and co-authored legal overview chapters in numerous local and international editions, as well as analytical articles in relation to life sciences regulation in the Baltics, pharmaceutical pricing and reimbursing issues.

Articles